These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7018790)

  • 1. Triamterene-thiazide combination: alternative therapy for primary aldosteronism.
    Ganguly A; Weinberger MH
    Clin Pharmacol Ther; 1981 Aug; 30(2):246-50. PubMed ID: 7018790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term medical management of aldosterone-producing adenoma.
    Bornemann M
    South Med J; 1990 Apr; 83(4):461-2. PubMed ID: 2108504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
    Ganguly A; Luetscher JA; Weinberger MH
    Clin Exp Hypertens A; 1982; 4(9-10):1695-714. PubMed ID: 6291813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Properties and indications of potassium-sparing diuretics].
    Rorive G; Krzesinski JM
    Rev Med Liege; 1986 May; 41(9):330-6. PubMed ID: 3523669
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension.
    Jeunemaitre X; Charru A; Chatellier G; Degoulet P; Julien J; Plouin PF; Corvol P; Ménard J
    Am J Cardiol; 1988 Nov; 62(16):1072-7. PubMed ID: 3189169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.
    Ma J; Albornoz F; Yu C; Byrne DW; Vaughan DE; Brown NJ
    Hypertension; 2005 Aug; 46(2):313-20. PubMed ID: 15998706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative potency of spironolactone, triamterene and potassium chloride in thiazide-induced hypokalaemia.
    Jackson PR; Ramsay LE; Wakefield V
    Br J Clin Pharmacol; 1982 Aug; 14(2):257-63. PubMed ID: 7104176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
    Griffing GT; Melby JC
    Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG; Hollifield JW; Liddle GW
    JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
    [No Abstract]   [Full Text] [Related]  

  • 10. Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
    Takeda R; Yamazaki T; Ito Y; Koshida H; Morise T; Miyamori I; Hashimoto T; Morimoto S
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):186-90. PubMed ID: 1311894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current problems in primary aldosteronism--4 cases of normokalemic primary aldosteronism (1st degree) caused by adenoma and 3 cases of aldosteronism, 1st degree, caused by hyperplasia (2 hypokalemic cases, a normokalemic case)].
    Oda T
    Naika; 1969 Oct; 24(4):713-24. PubMed ID: 5358678
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic value of calcium antagonists in autonomous hyperaldosteronism.
    Stimpel M; Ivens K; Volkmann HP; Wambach G; Kaufmann W
    Klin Wochenschr; 1989 Feb; 67(4):248-52. PubMed ID: 2648061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of potassium chloride or triamterene in thiazide hypokalemia.
    Papademetriou V; Burris J; Kukich S; Freis ED
    Arch Intern Med; 1985 Nov; 145(11):1986-90. PubMed ID: 3904654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma electrolytes in elderly patients taking fixed combination diuretics.
    Bayer AJ; Farag R; Browne S; Pathy MS
    Postgrad Med J; 1986 Mar; 62(725):159-62. PubMed ID: 3714599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRIMARY ALDOSTERONISM AND THE EFFECTS OF TWO MINERALOCORTICOID INHIBITORS--TRIAMTERENE AND SPIRONOLACTONE (ALDACTONE).
    ROBERTSON GL; DAWSON JW
    Can Med Assoc J; 1964 May; 90(20):1170-3. PubMed ID: 14145473
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of bemetizide-triamterene on the serum and whole body potassium in hypertensive patients (author's transl)].
    Schäfer GE; Werner E
    MMW Munch Med Wochenschr; 1978 Nov; 120(45):1505-7. PubMed ID: 101820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone and triamterene in volume-dependent essential hypertension.
    DeCarvalho JG; Emery AC; Frohlich ED
    Clin Pharmacol Ther; 1980 Jan; 27(1):53-6. PubMed ID: 6985854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absence of long-term therapeutic effect of calcium channel blockade in the primary aldosteronism of adrenal adenomas.
    Bursztyn M; Grossman E; Rosenthal T
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):88S-90S. PubMed ID: 3046636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism.
    Sakamoto H; Ichikawa S; Sakamaki T; Nakamura T; Ono Z; Takayama Y; Murata K
    Am J Hypertens; 1990 Jul; 3(7):533-7. PubMed ID: 2194510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.